Inspection Record

Home Care Pharmacy of Palm Coast, Inc. — FDA 483 Findings

US FDAInspected 2018-05-31Published 2024-01-17 3 findingsContamination controlMaterial and supplier control

Inspectors Jennifer L HuntingtonThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

You produced hazardous drugs without providing adequate containment, segregation and cleaning of work surfaces to prevent cross-contamination.

2Contamination control

You produced beta-lactam drugs without providing adequate containment, segregation and cleaning of work surfaces to prevent cross-contamination.

3Material and supplier control

You used a non-pharmaceutical grade component in the formulation ofa drug product.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Home Care Pharmacy of Palm Coast, Inc. company profile — full history US FDA documents, 2024 Go to Findings search